Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2005
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050245443 Bacteria strain and bacteriocin produced therefrom
11/03/2005US20050245437 Peptides having antimicrobial properties and compositions containing them, notably for the preservation of foodstuffs
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244515 Anti-microbial agent and anti-microbial composition
11/03/2005US20050244508 Anti-spasmodic comprising xenon
11/03/2005US20050244447 Novel drug dosing regimen
11/03/2005US20050244436 Combination Neisserial compositions
11/03/2005US20050244435 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
11/03/2005US20050244433 Administering vaccine comprising human papillomavirus L1 protein and excludes E protein to induce immune response
11/03/2005US20050244432 Expression of an L1 protein or functional protein derivative from two different types of papillomaviruses, and mixing the two; used for the prevention or treatment of a disease related to papillomavirus infection, such as cervical cancer or genital warts
11/03/2005US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus
11/03/2005US20050244415 administering an antibody which recognizes an extracellular domain of signal regulatory protein-beta (SIRP-beta); treatment of infections or cancer
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005DE202005008010U1 Fermented preparation, useful for medicinal therapy and to kill e.g. bacteria, fungi and virus, comprises grapes cider, additive of herb extract and honey
11/03/2005CA2807787A1 Hmb compositions and uses thereof
11/03/2005CA2564356A1 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
11/03/2005CA2564137A1 Treatment of fungal infections
11/03/2005CA2563741A1 Antisense oligonucleotides against cpla2, compositions and uses thereof
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005CA2562812A1 Imidazopyridine compound
11/03/2005CA2561146A1 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1h-pyrrolo[2-,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine for use in treating hiv infection
11/03/2005CA2560042A1 Hmb compositions and uses thereof
11/02/2005EP1591524A1 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591437A2 Interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
11/02/2005EP1591120A1 Receptor agonists
11/02/2005EP1590442A2 Macrocyclic hepatitis c serine protease inhibitors
11/02/2005EP1590372A2 Trimeric polypeptide construct to induce an enduring t cell response
11/02/2005EP1590360A1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
11/02/2005EP1590349A1 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
11/02/2005EP1590046A2 Composition for the treatment of hiv or aids
11/02/2005EP1589995A1 Use of avian antibodies
11/02/2005EP1589972A1 Benzoquinolizine-2-carboxylic acid-containing compositions
11/02/2005EP1589941A1 Composition for preventive treatment of cold sores
11/02/2005EP1589931A2 RNAi TARGETING OF VIRUSES
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1383749B1 Arylsulfonamides as antiviral agents
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1307227B1 Pharmaceutical compositions
11/02/2005EP1254164B1 Selective n-acylation of a82846 glycopeptide analogs
11/02/2005EP1246826B1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1200563B1 Attenuated influenza virus useful as vaccine
11/02/2005EP1169244B1 Metering valve
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP1067944B1 Combined preparation comprising monocyte derived cells and chemotherapy drugs for the treatment of neoplasic diseases or of infectious diseases
11/02/2005EP1005493B1 Antiviral protease inhibitors
11/02/2005EP1002092B1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/02/2005EP0793675B1 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission
11/02/2005CN1692156A Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
11/02/2005CN1692120A Inhibitors of nucleoside phosphorylases and nucleosidases
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692101A 4-oxoquinoline compounds and utilization thereof as HIV integrase inhibitors
11/02/2005CN1691962A Improvements of bacterin or related to bacterin
11/02/2005CN1691959A Interleukin 6 production inhibitor
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1225553C Recombinant pseudo-rabies virus expressing swine parvovirus VP gene and vaccine and its preparation method
11/02/2005CN1225464C Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine
11/02/2005CN1225268C 'Sanhuang' dripping pills and preparing method thereof
11/02/2005CN1225265C Medicine for treating wind-heat syndrome due to exopathy and preparation process thereof
11/02/2005CN1225263C Chinese herbal medicine for birds and beasts use and its preparing method
11/02/2005CN1225257C External applied medicine for treating hepatitis
11/02/2005CN1225256C Use of golden bell core or its extract in preparation of antibacterial and antivirus medicine or health care preparation
11/02/2005CN1225246C Releasing improved pharmaceutical preparation containing amoxicillin
11/02/2005CN1225245C Use of Pidotimod in preparation of hepatitis B treating medicine
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960600 a triazole or amidazole compound containing oxy, hydroxy or aromatic rings; active on candidoses, cryptococcoses caused by Candida albicans; prevention of mycosic diseases in individuals with immunodeficiency.
11/01/2005US6960585 For therapy of inflammatory and immune diseases
11/01/2005US6960569 Hepatitis C virus non-structural NS3/4A fusion gene
11/01/2005US6960564 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/01/2005US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
11/01/2005CA2281496C New hydroxy derivatives of tylosin and process for their preparation
10/2005
10/30/2005CA2507566A1 Carnobacterium divergens m35 and bacteriocin produced therefrom
10/27/2005WO2005100568A1 Recombined dna, pasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/27/2005WO2005100554A1 Novel infectious bursa fabricii's disease virus and vaccine containing the virus
10/27/2005WO2005100547A1 Dendritic cell obtained by antigen pulsing
10/27/2005WO2005100400A1 Humanized antibody against s-surface antigen of hepatitis b virus
10/27/2005WO2005100374A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/27/2005WO2005099765A1 Liquid composition and process for producing the same
10/27/2005WO2005099764A1 Antifungal composition for external use
10/27/2005WO2005099733A1 Vegetable antibacterial composition
10/27/2005WO2005099731A1 Antibacterial agent derived from galenical and composition for external application containing the same
10/27/2005WO2005099683A1 Antibacterial agent whose active ingredint is methyl paraoxybenzoate and composition for external application containing the same
10/27/2005WO2005099671A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005WO2005046567B1 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same
10/27/2005WO2005044823A3 Polymorphous forms of rifaximin as antibiotics
10/27/2005WO2003072595A3 Methods and products based on oligomerization of stress proteins
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005WO2002057313A8 Receptor-binding compounds and methods for identifying them
10/27/2005US20050240035 polymerase inhibitors such as -1-(5-Cyano-pyridin-2-yl)-3-(1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea, used as antiviral agents
1 ... 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 ... 1798